According to a market report by Lucintel, the future of the global infertility diagnosis and treatment market looks promising with opportunities in the male infertility treatment and female infertility treatment markets. The global infertility diagnosis and treatment market is expected to reach an estimated $2.9 billion by 2030 from $1.8 billion in 2023,at a CAGR of 7.9% from 2024 to 2030. The major drivers for this market are declining fertility rate, increasing availability of various fertility treatment options, and rising number of fertility centers across the globe.
A more than 150-page report to understand trends, opportunity and forecast in infertility diagnosis and treatment market to 2030 by diagnosis (male infertility diagnosis and female infertility diagnosis), treatment (male infertility treatment, female infertility treatment, and Others), and region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel forecasts that female infertility diagnosis is expected to witness higher growth over the forecast period.
Female infertility treatment will remain the largest segment.
Download sample by clicking on infertility diagnosis and treatment market
North America will remain the largest segment over the forecast period due to the changing lifestyle and growing geriatric population.
Bayer AG, Bristol-Myers Squibb, Church & Dwight, Cook Medical, Coopersurgical, Eli Lilly, EMD Serono, Endo Pharmaceuticals, Ferring Pharmaceuticals, Geneaare the major suppliers in the infertility diagnosis and treatment market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at [email protected]To get access of more than 1000 reports at fraction of cost visit Lucintel'sAnalytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market &unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: [email protected]
Tel. +1-972-636-5056
Explore Our Latest Publications
Comments on “Lucintel Forecasts the Global Infertility Diagnosis and Treatment Market to Reach $2.9 billion by 2030”